Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer

BACKGROUND: Human species C adenovirus serotype 5 (Ad5) is the archetype oncolytic adenovirus and has been used in the vast majority of preclinical and clinical tests. While Ad5 can be robust, species C Ad6 has lower seroprevalence, side effects, and appears to be more potent as a systemic therapy a...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncolytic Virother
Главные авторы: Nguyen, Tien V, Crosby, Catherine M, Heller, Gregory J, Mendel, Zachary I, Barry, Mary E, Barry, Michael A
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2018
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5939883/
https://ncbi.nlm.nih.gov/pubmed/29765912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OV.S155946
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы